BU and Johnson & Johnson Innovation Team Up to Fight Lung Cancer

June 6, 2018
In what Boston University President Robert A. Brown envisions as a model for industry and academia collaborating to improve human health, BU has launched a five-year translational research alliance with Johnson & Johnson Innovation LLC (JJI) aimed at preventing, intercepting, and curing lung cancer, the leading cause of cancer deaths worldwide.As part of the new alliance, Johnson & Johnson Innovation will fund a Johnson & Johnson Innovation Lung Cancer Center at Boston University on the Medical Campus, where BU researchers will work closely with members of the Lung Cancer Initiative within Johnson & Johnson to develop biomarker-based early-screening tests for lung cancer, as well as therapeutics to arrest or eradicate the disease in its earliest stages. The goal is to combine the resources of healthcare giant J&J with expertise at Boston University to speed the development of interventions and cures.Read the full article here.

Learn More

What is Public Relations?

Whether you’re looking to promote your research, a new initiative, an event, or are preparing for an interview with national media, BU Public Relations is here to help. We’ll work with you to focus your message, develop a communication strategy, and get the word out.

Learn About Our Services Get In Touch